{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:52:11Z","timestamp":1773867131453,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.3816\/clm.2003.n.003","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:04Z","timestamp":1221095404000},"page":"225-232","source":"Crossref","is-referenced-by-count":27,"title":["Recombinant Urate Oxidase for Prevention of Hyperuricemia and Tumor Lysis Syndrome in Lymphoid Malignancies"],"prefix":"10.3816","volume":"3","author":[{"given":"Raul C.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2003.n.003_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Non-Hodgkin's lymphoma in childhood","volume":"334","author":"Sandlund","year":"1996","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14737140.1.1.43","article-title":"Advances in the management of patients with non-Hodgkin's lymphoma","volume":"1","author":"Lionberger","year":"2001","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.3816\/CLM.2003.n.003_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM194303042280901","article-title":"The renal complications of leukemia","volume":"228","author":"Merrill","year":"1943","journal-title":"New Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0002-9343(64)90130-5","article-title":"Uric acid excretion and renal function in the acute hyperuricemia of leukemia","volume":"37","author":"Rieselbach","year":"1964","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0002-9343(75)90597-5","article-title":"American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I: clinical factors relating to prolonged survival","volume":"58","author":"Arseneau","year":"1975","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9343(80)90286-7","article-title":"Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma","volume":"68","author":"Cohen","year":"1980","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0002-9343(90)90358-K","article-title":"Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate","volume":"89","author":"List","year":"1990","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1097-0142(19900715)66:2<246::AID-CNCR2820660209>3.0.CO;2-B","article-title":"Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide","volume":"66","author":"McCroskey","year":"1990","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.003_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0025-7125(16)30522-3","article-title":"Acute uric acid nephropathy","volume":"74","author":"Conger","year":"1990","journal-title":"Med Clin North Am"},{"key":"10.3816\/CLM.2003.n.003_bib11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1976.03270090055038","article-title":"Uric acid nephropathy","volume":"236","author":"Perry","year":"1976","journal-title":"JAMA"},{"key":"10.3816\/CLM.2003.n.003_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM197312202892503","article-title":"Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia","volume":"289","author":"Zusman","year":"1973","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0002-9343(77)90324-2","article-title":"Hyperphosphatermia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia","volume":"62","author":"Cadman","year":"1977","journal-title":"Am J Med"},{"issue":"suppl 10","key":"10.3816\/CLM.2003.n.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90036-8","article-title":"Optimal treatment of malignancies associated with hyperuricemia","volume":"38","author":"Pui","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.n.003_bib15","first-page":"273","article-title":"Tumor lysis syndrome","volume":"13","author":"Arrambide","year":"1993","journal-title":"Semin Nephrol"},{"issue":"suppl 10","key":"10.3816\/CLM.2003.n.003_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0037-1963(01)90037-X","article-title":"Tumor lysis syndrome","volume":"38","author":"Jeha","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.n.003_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.28.4.366","article-title":"Studies of uric acid pool size and turnover rate","volume":"28","author":"Scott","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.3816\/CLM.2003.n.003_bib18","series-title":"Disorders associated with purine and pyrimidine metabolism. Special topics in endocrinology and metabolism","first-page":"95","author":"Cohen","year":"2002"},{"key":"10.3816\/CLM.2003.n.003_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3476(78)80359-X","article-title":"Uric acid excretion in normal children","volume":"92","author":"Stapleton","year":"1978","journal-title":"J Pediatr"},{"key":"10.3816\/CLM.2003.n.003_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02474201","article-title":"Solubility of uric acid and monosodium urate","volume":"10","author":"Wilcox","year":"1972","journal-title":"Mol Biol Eng"},{"key":"10.3816\/CLM.2003.n.003_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM198707093170209","article-title":"Hyperuricemia: a marker for cell energy crisis","volume":"317","author":"Fox","year":"1987","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1172\/JCI105493","article-title":"Studies of the mechanism by which phosphate infusion lowers serum calcium concentration","volume":"45","author":"Hebert","year":"1966","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2003.n.003_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0272-6386(88)80060-X","article-title":"Hyperphosphatemia, hypocalcemia, and renal failure in a patient with acute leukemia","volume":"11","author":"Allon","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.3816\/CLM.2003.n.003_bib24","first-page":"47","article-title":"Transient acute renal failure due to tumor-lysis-induced severe phosphate load in a patient with Burkitt's lymphoma","volume":"22","author":"Monballyu","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.3816\/CLM.2003.n.003_bib25","first-page":"429","article-title":"Acute renal failure induced by hyperphosphatemia in acute lymphoblastic leukemia","volume":"124","author":"Kaplan","year":"1981","journal-title":"Can Med Assoc J"},{"key":"10.3816\/CLM.2003.n.003_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM197008132830708","article-title":"Xanthine nephropathy in a patient wtih lymphosarcoma treated with allopurinol","volume":"283","author":"Band","year":"1970","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(86)80387-0","article-title":"Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure","volume":"109","author":"Andreoli","year":"1986","journal-title":"J Pediatr"},{"key":"10.3816\/CLM.2003.n.003_bib28","first-page":"F423","article-title":"A proposed role for adenosine in the regulation of renal hemodynamics and renin release","volume":"242","author":"Spielman","year":"1982","journal-title":"Am J Physiol"},{"issue":"3 Pt 2","key":"10.3816\/CLM.2003.n.003_bib29","first-page":"F340","article-title":"Interactions between adenosine and angiotensin II in controlling glomerular filtration","volume":"248","author":"Hall","year":"1985","journal-title":"Am J Physiol"},{"key":"10.3816\/CLM.2003.n.003_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-2008-1043892","article-title":"Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials","volume":"210","author":"Seidemann","year":"1998","journal-title":"Klin Padiatr"},{"key":"10.3816\/CLM.2003.n.003_bib31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1542\/peds.82.6.863","article-title":"Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic leukemia","volume":"82","author":"Stapleton","year":"1988","journal-title":"Pediatrics"},{"key":"10.3816\/CLM.2003.n.003_bib32","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1016\/S0272-6386(99)70062-4","article-title":"Hyperuricemia and renal insufficiency associated with malignant disease: urate oxidase as an efficient therapy?","volume":"34","author":"Wolf","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.3816\/CLM.2003.n.003_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2257.1998.00124.x","article-title":"Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy","volume":"20","author":"Leach","year":"1998","journal-title":"Clin Lab Haematol"},{"key":"10.3816\/CLM.2003.n.003_bib34","first-page":"158","article-title":"A new method for the preparation of uncase and the effect of uricase on the blood uric acid levels of the chicken","volume":"21","author":"Altman","year":"1949","journal-title":"Arch Biochem"},{"key":"10.3816\/CLM.2003.n.003_bib35","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.125.3254.937","article-title":"Uricolytic activity of purified uricase in two human beings","volume":"125","author":"London","year":"1957","journal-title":"Science"},{"key":"10.3816\/CLM.2003.n.003_bib36","first-page":"811","article-title":"Urate oxidase of Aspergillus flavus. I: isolation, purification, properties","volume":"50","author":"Laboureur","year":"1968","journal-title":"Bull Soc Chim Biol (Paris)"},{"key":"10.3816\/CLM.2003.n.003_bib37","first-page":"827","article-title":"Urate oxidase of Aspergillus flavus. II: metabolism, inhibition, specificity","volume":"50","author":"Laboureur","year":"1968","journal-title":"Bull Soc Chim Biol (Paris)"},{"key":"10.3816\/CLM.2003.n.003_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/217072a0","article-title":"Modification of uricaemia and the excretion of uric acid nitrogen by an enzyme of fungal origin","volume":"217","author":"Kissel","year":"1968","journal-title":"Nature"},{"key":"10.3816\/CLM.2003.n.003_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-3476(82)80259-X","article-title":"Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia","volume":"100","author":"Masera","year":"1982","journal-title":"J Pediatr"},{"key":"10.3816\/CLM.2003.n.003_bib40","first-page":"89","article-title":"Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient","volume":"35","author":"Ducros","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.3816\/CLM.2003.n.003_bib41","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"},{"issue":"suppl 10","key":"10.3816\/CLM.2003.n.003_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0037-1963(01)90038-1","article-title":"European experience in the treatment of hyperuricemia","volume":"38","author":"Patte","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.n.003_bib43","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","article-title":"Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study","volume":"14","author":"Bowman","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.003_bib44","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non- Hodgkin's lymphoma (B-NHL)\u2014results of the UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2003.n.003_bib45","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.003_bib46","first-page":"370a","article-title":"Recombinant urate oxidase (rasburicase) prevents uric acid accumulation during chemotherapy as evidenced by urinary allantoin excretion","volume":"21","author":"Pui","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.003_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","article-title":"Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma","volume":"19","author":"Pui","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.003_bib48","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.003_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14656566.3.4.433","article-title":"Rasburicase: a potent uricolytic agent","volume":"3","author":"Pui","year":"2002","journal-title":"Exp Opin Pharmacother"},{"key":"10.3816\/CLM.2003.n.003_bib50","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/sj.leu.2402235","article-title":"Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial","volume":"15","author":"Pui","year":"2001","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2003.n.003_bib51","first-page":"556a","article-title":"Recombinant urate oxidase (rasburicase, Elitek) for prevention and treatment of malignancy-associated hyperuricemia: updated results of a compassionate use trial","volume":"100","author":"Pui","year":"2002","journal-title":"Blood"},{"issue":"suppl 10","key":"10.3816\/CLM.2003.n.003_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0037-1963(01)90039-3","article-title":"Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience","volume":"38","author":"Pui","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.n.003_bib53","unstructured":"Navolanic PM, Pui CH, Larson RA, et al. Elitek\u2122 rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome: a meeting report, Dallas, Texas, January 2002. Leukemia. In press."},{"key":"10.3816\/CLM.2003.n.003_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(68)90008-9","article-title":"Renal clearance of oxipurinol, the chief metabolite of allopurinol","volume":"45","author":"Elion","year":"1968","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.003_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM196902202800806","article-title":"Urinary xanthine stones\u2014a rare complication of allopurinol therapy","volume":"280","author":"Greene","year":"1969","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.003_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jama.1979.03300040043027","article-title":"Management of gout","volume":"242","author":"Fox","year":"1979","journal-title":"JAMA"},{"key":"10.3816\/CLM.2003.n.003_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.40.3.245","article-title":"Acute adverse reactions attributed to allopurinol in hospitalised patients","volume":"40","author":"McInnes","year":"1981","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:10:51Z","timestamp":1738361451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511701828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S1526965511701828"],"URL":"https:\/\/doi.org\/10.3816\/clm.2003.n.003","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}